Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Cytosorbents (CTSO) Gross Profit (2016 - 2026)

Cytosorbents filings provide 15 years of Gross Profit readings, the most recent being $6.8 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 8.78% to $6.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $26.5 million, a 6.44% increase, with the full-year FY2025 number at $26.5 million, up 6.45% from a year prior.
  • Gross Profit hit $6.8 million in Q4 2025 for Cytosorbents, up from $6.7 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $9.3 million in Q2 2021 to a low of $3.6 million in Q3 2022.
  • Median Gross Profit over the past 5 years was $6.3 million (2022), compared with a mean of $6.3 million.
  • Biggest five-year swings in Gross Profit: tumbled 50.43% in 2022 and later skyrocketed 55.0% in 2023.
  • Cytosorbents' Gross Profit stood at $7.7 million in 2021, then fell by 24.84% to $5.8 million in 2022, then fell by 7.74% to $5.3 million in 2023, then rose by 17.77% to $6.3 million in 2024, then grew by 8.78% to $6.8 million in 2025.
  • The last three reported values for Gross Profit were $6.8 million (Q4 2025), $6.7 million (Q3 2025), and $6.8 million (Q2 2025) per Business Quant data.